FAQ

poly(maleic acid-styrene)neocarzinostatin

Known as: SMANCS, copoly(styrene-maleic acid)neocarzinostatin, zinostatin stimalamer 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1979-2017
0102019792017

Related topics

Related topics

5 relations

Broader (4)

Antineoplastic AgentsMaleic AnhydridesPolystyrenesZinostatin

Narrower (1)

YM 881

Related mentions per year

Related mentions per year

1947-2018
19401960198020002020
poly(maleic acid-styrene)neocarzinostatin
Polystyrenes
Antineoplastic Agents
Zinostatin
YM 881
Maleic Anhydrides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors.
The purpose of this study is to evaluate the improved method of arterial infusion therapy of SMANCS (SX) with lipiodol under the… (More)
  • figure 1
  • figure 2
  • figure 2
  • figure 3
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival…
OBJECTIVE We assessed the local recurrence rate after a single targeted transarterial oily chemoembolization for small… (More)
Is this relevant?
1989
1989
Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin
The development of non-specific resistance to tumors following stimulation with poly(maleic-acid-styrene)-conjugated… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
1987
1987
[Tumor growth inhibitory effects of SMANCS, a poly (styrene-maleic acid) conjugated derivative of neocarzinostatin, on various tissue culture cells].
Growth inhibitory effects of neocarzinostatin (NCS), and its conjugated derivative with poly (styrene-maleic acid), SMANCS, were… (More)
Is this relevant?
1985
1985
Conjugation of poly(styrene-co-maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological properties.
An anticancer agent of intermediate molecular weight and having both a hydrophilic and hydrophobic nature was developed by… (More)
Is this relevant?
Highly Cited
1984
Highly Cited
1984
Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium.
Twenty-four patients with various solid tumors including metastatic liver cancer and cancer of the lung, gallbladder, and… (More)
Is this relevant?
Highly Cited
1984
Highly Cited
1984
Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image.
Highly malignant rabbit tumor (VX-2) was implanted at the periphery of the liver in 63 rabbits. Selective delivery of the… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
1983
Highly Cited
1983
Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report.
A clinical evaluation of arterial infusion of high-molecular-weight antitumor agent SMANCS dissolved in lipid lymphographic agent… (More)
Is this relevant?
1982
1982
In vitro mode of action, pharmacokinetics, and organ specificity of poly (maleic acid-styrene)-conjugated neocarzinostatin, SMANCS.
The organ specificity and pharmacokinetics of SMANCS, poly (maleic acid-styrene)-conjugated neocarzinostatin (NCS), were… (More)
Is this relevant?
1979
1979
A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic.
A lipophilic derivative of neocarzinostatin (NCS), an antitumor antibiotic, was prepared by reaction with a synthetic water… (More)
Is this relevant?